Litcius/Paper detail

Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment

Yoichi Ohtaki, Kimihiro Shimizu, Hiroyuki Suzuki, Kenji Suzuki, Masahiro Tsuboi, Tetsuya Mitsudomi, Motoshi Takao, Tomohiro Murakawa, Hiroyuki Ito, Kenichi Yoshimura, Morihito Okada, Masayuki Chida

2021Lung Cancer56 citationsDOI

Topics & Concepts

MedicineInternal medicineHazard ratioAnaplastic lymphoma kinasePerioperativeOncologyLung cancerCarcinoembryonic antigenGastroenterologyUnivariate analysisTyrosine-kinase inhibitorClinical endpointConfidence intervalSurgeryCancerClinical trialMultivariate analysisMalignant pleural effusionLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentGastric Cancer Management and Outcomes
Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment | Litcius